Indefinite Delivery Contract 36C24223D0041

The Department of Veterans Affairs awarded Boston Scientific Corporation a single award indefinite delivery contract to provide surgical implants and related services in support of Veterans Health Administration programs. The contract has a potential value of up to $295 million over a five year ordering period, with no set-aside designations applied. Delivery orders issued to date total over $2.5 million.

Boston Scientific will supply a range of implantable medical devices under the contract. Based on the company's portfolio and previous federal contracts, this likely includes products for cardiac rhythm management such as pacemakers and implantable cardioverter defibrillators, as well as coronary and peripheral vascular stents. The contract also encompasses related supplies, equipment, and service requirements to support the implantation of these devices at VA medical centers nationwide. As the sole awardee, Boston Scientific is positioned to be the VA's primary provider of implantable cardiac devices and supplies through 2028, aiming to ensure Veterans have access to state-of-the-art treatments for conditions like arrhythmias and blockages in the arteries of the heart and blood vessels.

Additionally, the VA issued Boston Scientific a separate $3.5 million indefinite delivery contract for interventional radiology services and Yttrium-90 TheraSphere microspheres. Over $1.3 million in delivery orders were placed in the first year of that contract's period of performance, which extends through September 2028. The radiopharmaceutical microspheres are intended to treat cancerous tumors in the liver as a minimally invasive alternative to surgery. This award leverages Boston Scientific's expertise in brachytherapy to expand treatment options available to Veterans suffering from conditions like hepatocellular carcinoma.